Sort
82,697 grants matching “vaccine development”
Self-administered microneedle patches for influenza vaccines
$1,450,383Richard W Compans · Emory University · U01 · FY2009 · AI
Chicago Clinical Trials Unit
$1,450,349Robert L. Murphy · Northwestern University At Chicago · UM1 · FY2015 · AI
Toward a universal influenza virus vaccine based on live attenuated NS1-deleted influenza viruses
$1,450,070Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · AI
DCTD Biopharmaceutical Development - Type 1 Diabetes RAID projects
$1,450,000Larry Arthur · Science Applications International Corp · N01 · FY2009 · CA
Georgetown University, Lombardi Cancer Center Support Grant Competitive Renewal
$1,449,710Louis M Weiner · Georgetown University · P30 · FY2013 · CA
Structure-Based Vaccine Design for Hepatits C Virus
$1,449,630Thomas R Fuerst · Univ Of Maryland, College Park · R01 · FY2017 · AI
Studies of Receptor Interactions and Effects of Alarmins
$1,449,620Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
$1,449,048Nicolas Collins · Vaccine Formulation Institute (Ch) Ltd · N01 · FY2023 · AI
Immunogen Design for Induction of HIV distal gp41 broadly neutralizing antibodies
$1,449,025S Munir Alam · Duke University · P01 · FY2023 · AI
Whole Protein Arrays to Detect Antimicrobial Antibodies Associated with Triggering and Progression of Islet Autoimmunity in TEDDY
$1,449,016Joshua Labaer · Arizona State University-Tempe Campus · R01 · FY2024 · DK
Flavivirus Infections: Pathogenesis and Prevention
$1,449,015Univ Of Massachusetts Med Sch Worcester · P01 · FY2005 · AI
Vector-Borne Diseases: Biology Of Vector Host Relationship
$1,449,000Jose Ribeiro · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Non-Human Primate Core
$1,448,934Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIC · FY2018 · AI
Core N: Biostatistics and Modeling
$1,448,230Sonia Jain · University Of California, San Diego · P30 · FY2021 · AI
Alphavirus Replicon Vaccines against Botulinum Neurotox*
$1,448,108Jeffrey D Chulay · Alphavax Human Vaccines, Inc. · U01 · FY2006 · AI
HIV/SIV Replication In Vivo
$1,447,716Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Development of a flagellin-cocaine conjugate vaccine
$1,447,504Steven B. Mizel · Wake Forest University Health Sciences · RC2 · FY2010 · DA
Antigenicity and Immunogenicity of Stabilized prefusion F protein
$1,447,312Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Mechanisms of naturally-acquired immunity to malaria
$1,447,236Peter Crompton · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Administrative Core
$1,447,136Ronald G Collman · University Of Pennsylvania · P30 · FY2020 · AI
Core 2: Biocontainment and Immune Monitoring Core
$1,447,074Gregory D Sempowski · Duke University · P01 · FY2023 · AI
Non-invasive Optical Imaging of Select Agent Bacteria in Non-human Primates
$1,446,962D Mark Estes · University Of Texas Med Br Galveston · U01 · FY2009 · AI
Genetic Risk Variants in Atopic Dermatitis Associated with Eczema Herpeticum
$1,446,644Donald Ym Leung · National Jewish Health · U19 · FY2016 · AI
Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease
$1,446,418Frederick Miller · National Institute Of Environmental Health Sciences · ZIA · FY2010 · ES
Ecopathogenomics of sexually transmitted infections (EPSTI)
$1,446,401Patrik M Bavoil · University Of Maryland Baltimore · U19 · FY2018 · AI